What is the management for an adult with a triglycerides (TG) to High-Density Lipoprotein (HDL) ratio of 1.21, due to hypertriglyceridemia and low HDL, without a significant past medical history?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of TG/HDL Ratio of 1.21 (TG 92 mg/dL, HDL 76 mg/dL)

Your lipid profile is excellent and requires no pharmacologic intervention

Your triglyceride-to-HDL ratio of 1.21 with triglycerides at 92 mg/dL and HDL at 76 mg/dL represents optimal lipid parameters that are strongly protective against cardiovascular disease. 1

Why No Treatment Is Needed

Triglyceride Level Assessment

  • Your triglycerides at 92 mg/dL are well below the normal threshold of <150 mg/dL 2
  • This level is classified as normal and does not meet criteria for any intervention 3, 2
  • Pharmacologic therapy for triglycerides is only considered when levels exceed 200 mg/dL after lifestyle optimization, or immediately when ≥500 mg/dL to prevent pancreatitis 3, 2

HDL Cholesterol Assessment

  • Your HDL at 76 mg/dL exceeds the protective threshold of >40 mg/dL for men or >50 mg/dL for women 3
  • This HDL level is associated with significantly reduced cardiovascular risk 1
  • The combination of low triglycerides (<97 mg/dL) and high HDL (>57 mg/dL) confers the lowest risk profile for ischemic heart disease 1

TG/HDL Ratio Interpretation

  • A TG/HDL ratio of 1.21 is well below the concerning threshold of ≥2.5 that predicts increased mortality and cardiovascular events 4
  • Ratios below 2.5 are not associated with adverse outcomes in high-risk populations 4

Recommended Approach

Maintain Current Status

  • Continue standard cardiovascular risk reduction through lifestyle measures: maintain healthy weight, engage in regular physical activity (≥150 minutes/week moderate-intensity exercise), follow a heart-healthy diet with <7% saturated fat, and avoid smoking 2
  • Recheck lipid panel every 2 years if values remain in low-risk range 3

No Pharmacologic Intervention Indicated

  • Neither fibrates, niacin, nor statins are indicated with your current lipid profile 3
  • Statin therapy would only be considered based on your LDL cholesterol level and overall cardiovascular risk assessment, not based on these triglyceride or HDL values 3, 2

Critical Context

  • The evidence for pharmacologic intervention targets patients with triglycerides ≥150 mg/dL (particularly ≥200 mg/dL) and/or HDL <40 mg/dL 3, 2
  • Your values fall outside these treatment thresholds entirely 3, 2

References

Guideline

Hypertriglyceridemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What interventions are recommended for a 36-year-old patient with hyperlipidemia (elevated lipid profile), characterized by hypertriglyceridemia (triglycerides 221), low high-density lipoprotein (HDL) cholesterol (45), hypercholesterolemia (total cholesterol 327), elevated very-low-density lipoprotein (VLDL) cholesterol (45), and elevated low-density lipoprotein (LDL) cholesterol (237)?
What is the next best step for a 55-year-old post-menopausal female with hypercholesterolemia (elevated cholesterol), elevated low-density lipoprotein (LDL) levels, and normal high-density lipoprotein (HDL) and triglyceride levels, with no known comorbidities?
What is the best treatment plan, including pharmacological and non-pharmacological interventions, for a 48-year-old male with hypertriglyceridemia (Trig 195), low high-density lipoprotein (HDL 28), elevated low-density lipoprotein (LDL 122), elevated hematocrit (Hct 53.1), macrocytosis (MCV 100), and mildly elevated bilirubin (Bili 1.7), who is currently taking testosterone replacement therapy (TRT)?
Can someone with borderline high Low-Density Lipoprotein (LDL) eat gizzards?
What is the most suitable drug for a patient with hypercholesterolemia, marginally reduced High-Density Lipoprotein (HDL) and markedly elevated hypertriglyceridemia?
How to manage persistent urinary urgency, pelvic pain, and irritable bowel syndrome symptoms in a patient with a history of neuropathic pain and pelvic floor dysfunction?
Should I continue to use my Peripherally Inserted Central Catheter (PICC) line if I have signs of infection, such as moderate serous drainage and swelling, given my chronic condition?
What is the best course of management for a hypertensive patient with decreased sensorium, initial weakness, and subsequent improvement, with a negative computed tomography (CT) scan?
Does Augmentin (amoxicillin and clavulanic acid) cover gram-positive, gram-negative, and anaerobic organisms?
When should patients with atrial fibrillation, a history of stroke or transient ischemic attack (TIA), and stable coronary artery disease be on aspirin (acetylsalicylic acid (ASA)) and a Direct Oral Anticoagulant (DOAC), and what are the indications for triple antithrombotic therapy with a DOAC, ASA, and a P2Y12 inhibitor?
Is a Toradol (ketorolac) shot safe for a breastfeeding woman?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.